Routine Bile Culture From Liver Donors as Screening of Donor-Transmitted Infections in Liver Transplantation.
Journal
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
15
11
2019
revised:
07
03
2020
accepted:
04
04
2020
pubmed:
15
4
2020
medline:
19
3
2021
entrez:
15
4
2020
Statut:
ppublish
Résumé
Bacterial infections are an important threat in the early post-liver transplantation period. Donor-transmitted infections, although rare, can have high mortality. The utility of routine culture from the donor bile duct as screening of donor-transmitted infection has not been evaluated. We performed a retrospective study of 200 consecutive liver transplants between 2010 and 2015. Demographic, clinical, and microbiological data were collected from the recipients' medical records. Clinical data included pretransplantation, perioperative, and posttransplantation information (until 30 days after the procedure). The 3-month patient survival and/or retransplantation were recorded. A total of 157 samples from the donor bile duct were collected and cultured. Only 8 were positive. The microorganisms isolated were as follows: Klebsiella pneumoniae, n = 2; Escherichia coli, n = 1; Enterobacter cloacae, n = 1; Streptococcus anginosus, n = 1; Streptococcus sp., n = 1; multiple gram-negative bacilli, n = 1; and polymicrobial, n = 1. All of the microorganisms were susceptible to the antibiotic prophylaxis administered. During the first month after transplantation, 81 recipients developed 131 infections. Only 1 of these recipients had a donor with a positive bile culture, and none of the infections were due to the microorganism isolated in the donor's bile. The 3-month overall survival was 89.5%, and there were no differences between recipients with positive donor bile cultures and those with negative donor bile cultures (87.5% versus 89.26%; P > 0.99). Routine testing of donor bile cultures does not predict recipients' infection or survival after liver transplantation and should not be recommended.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1121-1126Informations de copyright
Copyright © 2020 by the American Association for the Study of Liver Diseases.
Références
Abbasoglu O. Liver transplantation: yesterday, today and tomorrow. World J Gastroenterol 2008;14:3117-3122.
Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:3-26.
European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation. J Hepatol 2016;64:433-485.
Grossi PA, Costa AN, Fehily D, Blumberg EA, Kuehnert MJ, Fishman JA, et al. Infections and organ transplantation: new challenges for prevention and treatment-a colloquium. Transplantation 2012;93(suppl):S4-S39.
Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation: donor-derived disease transmission. Am J Transplant 2011;11:1123-1130.
Greenwald MA, Kuehnert MJ, Fishman JA. Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis 2012;18:e1.
Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol 2014;20:6211-6220.
Ison MG, Hager J, Blumberg E, Burdick J, Carney K, Cutler J, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009;9:1929-1935.
Fishman JA, Greenwald MA, Grossi PA. Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012;55:720-727.
Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Grossi P; for ESCMID Study Group of Infection in Compromised Hosts. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 2014;20(suppl 7):10-18.
Len O, Gavaldà J, Blanes M, Montejo M, San Juan R, Moreno A, et al.; for Spanish Research network for the Study of Infection in Transplantation. Donor infection and transmission to the recipient of a solid allograft. Am J Transplant 2008;8:2420-2425.
Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010;72:284-291.
Sganga G, Bianco G, Fiori B, Nure E, Spanu T, Lirosi MC, et al. Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011. Transplant Proc 2013;45:2718-2721.
Schukfeh N, Doerner JM, Heintschel von Heinegg E, Steinmann J, Metzelder ML, Kathemann S, et al. Spectrum of pathogens in native liver, bile, and blood during pediatric liver transplantation. Pediatr Transplant 2014;18:266-271.
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, et al.; for Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI). Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev 2016;30:119-143.
Wu TJ, Lee CF, Chou HS, Yu MC, Lee WC. Suspect the donor with potential infection in the adult deceased donor liver transplantation. Transplant Proc 2008;40:2486-2488.
Kabar I, Hüsing A, Cicinnati VR, Heitschmidt L, Beckebaum S, Thölking G, et al. Analysis of bile colonization and intestinal flora may improve management in liver transplant recipients undergoing ERCP. Ann Transplant 2015;20:249-255.
Ison MG, Grossi P; for AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation. Am J Transplant 2013;13(suppl 4):22-30.
Fagiuoli S, Colli A, Bruno R, Craxì A, Gaeta GB, Grossi P, et al.; for 2011 ISF Single Topic Group. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 2014;60:1075-1089.